Log In
Print
BCIQ
Print
Print this Print this
 

Virexxa

  Manage Alerts
Collapse Summary General Information
Company Pharmsynthez JSC
DescriptionProgesterone receptor agonist
Molecular Target Progesterone receptor
Mechanism of ActionProgesterone receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationEndometrial cancer
Indication DetailsTreat advanced and relapsed hormone-resistant endometrial cancer
Regulatory Designation U.S. - Orphan Drug (Treat advanced and relapsed hormone-resistant endometrial cancer)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today